Test Price
2,800 AED✅ Home Collection Available
SGCB Gene Limb‑Girdle Muscular Dystrophy Autosomal Recessive Type 2E (LGMD2E) Genetic Test in UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity for LGMD2E via ISO‑accredited NGS processing.
- Sample Collection: VIP mobile phlebotomy with temperature‑controlled cold‑chain logistics, available daily 8 AM–11 PM.
- Post‑Test Guidance: Complimentary telephonic result interpretation with a certified genetic counsellor.
- Billing: Direct billing with select insurers; verify coverage via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced next‑generation sequencing test analyses the entire coding region of the SGCB gene to detect pathogenic variants causing autosomal recessive limb‑girdle muscular dystrophy type 2E (LGMD2E). Early molecular diagnosis enables precise prognosis, targeted management, and family cascade screening.
| Feature | Our NGS Test | Closest Alternative (Targeted Genotyping) |
|---|---|---|
| Detection Scope | Full gene sequencing – identifies all SNVs, indels, and novel variants | Only known founder mutations; misses rare/private variants |
| Method | NGS (Illumina® platform, 300× coverage) | Allele‑specific PCR / Sanger confirmation |
| Turnaround Time | 3 to 4 Weeks | 2–3 Weeks |
| Diagnostic Yield | >99% for LGMD2E | ~70–80% (population‑dependent) |
| Price | 2,800 AED | Often higher cumulative cost if reflex to NGS needed |
Physician Insight & Safety Protocols
“A positive SGCB result does not replace clinical judgement. I always correlate genetic findings with the patient’s full neuromuscular examination, family history, and ancillary tests. My team ensures every result is explained in context so families feel empowered, not overwhelmed.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Advisory
Medication Safety Notice
Do not discontinue any prescribed medication or alter your treatment plan without consulting your physician. Genetic testing does not replace acute clinical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent blood transfusion (within 8 weeks) may affect DNA integrity.
- Exclusion: Minors under 18 years without legal guardian consent as per applicable UAE family and health laws.
- Pre‑requisite: Provide a detailed clinical history and attend a pre‑test genetic counselling session to construct a family pedigree.
- ER Red Flag: If you experience sudden respiratory distress, severe muscle pain, or cardiac symptoms, proceed to the nearest emergency department immediately – do not wait for test results.
- ER Red Flag: Acute onset of weakness in bulbar muscles (difficulty swallowing/speaking) warrants emergency evaluation.
Patient FAQ & Clinical Guidance
1. What does the SGCB NGS test detect and who should consider it?
This next‑generation sequencing test detects disease‑causing mutations in the entire SGCB gene, confirming or ruling out LGMD2E diagnosis. It is recommended for patients with progressive proximal muscle weakness, elevated CK levels, and a family history of autosomal recessive myopathy. The test also enables carrier testing and prenatal decision‑making.
2. How is the sample collected and is home service compliant with UAE regulations?
A certified phlebotomist visits your home using an ISO‑certified cold‑chain kit to draw blood or collect a single drop on an FTA card. The process fully adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 for health information security. Confidentiality and informed consent are maintained throughout.
3. What happens after I receive the result?
You will receive a comprehensive report detailing the genetic variant, its clinical significance, and a complimentary telephonic session to interpret findings with a certified genetic counsellor. The report guides your neurologist in tailored management and family screening. If a variant of uncertain significance is found, follow‑up family studies may be suggested.
4. How long does the test take and what is the price?
Turnaround time is 3 to 4 weeks from sample receipt. The all‑inclusive price is 2,800 AED, covering genetic testing, home collection, and one telephonic counselling session.
5. Is the test covered by insurance?
We offer direct billing with select insurers. Please verify your coverage by contacting our billing team via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
All genetic testing and data handling at our DHA‑licensed facility comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical procedures and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your protected health information is encrypted and accessible only to authorised clinicians.
Clinical & Logistical Metadata
| Test Name | SGCB Gene Limb‑Girdle Muscular Dystrophy Autosomal Recessive Type 2E (LGMD2E) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina platform, 300× coverage |
| ICD‑10‑CM Code | G71.0 |
| LOINC Code | 76992-0 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians